WHO ICTRP trial
Intravenous iron in patients with heart failure and reduced ejection fraction…
EUCTR2016-004147-37-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2016-004147-37-DE |
|---|---|
| Public title | Intravenous iron in patients with heart failure and reduced ejection fraction (HFREF) plus iron deficiency: Effects upon phosphate and FGF23 metabolism - Iron Turtle |
| Scientific title | Intravenous iron in patients with heart failure and reduced ejection fraction (HFREF) plus iron deficiency: Effects upon phosphate and FGF23 metabolism - Iron Turtle |
| Primary sponsor | Center for Translational & Clinical Research Aachen (CTC-A) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Germany |
| Conditions | Systolic heart failure (heart failure with reduced ejection fraction, HFREF) + iron deficiency with serum ferritin <100 µg/l or 100 – 299 µg/L when transferrin saturation (TSAT) is <20%;Therapeutic area: Diseases [C] - Cardiovascular… |
| Interventions | Trade Name: Ferinject Pharmaceutical Form: Solution for injection/infusion |
| Registration date | Nov 24, 2016 |
| Target size | 24 |
| Secondary IDs | 16-047 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: